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Low anthocyanin plum nectar does not impact cognition, blood pressure and gut
microbiota in healthy older adults: A randomized crossover trial
Abstract
Queen Garnet plum (QGP), known for its high levels of anthocyanins, is a hybrid of the Japanese plum
developed in Queensland, Australia. Anthocyanins provide the red, blue and purple pigments in plants with
demonstrated beneficial health effects. This study hypothesized that low-dose anthocyanin QGP intake
will have a significant positive effect on cognition, blood pressure and gut microbiota in healthy older
adults. A randomized crossover trial was conducted to determine the effect and within subject variance
on cognition and 24 hr. ambulatory blood pressure in older adults without cognitive impairment following
daily consumption of 200 mL low-dose anthocyanin (5 mg/100 g) QGP nectar (intervention) or raspberry
cordial (control). Secondary outcomes included inflammatory markers (C-reactive protein), nerve growth
factor (BDNF), and gut microbiota (16S rRNA gene sequencing). Twenty-eight participants (55+ years)
were recruited. Each randomized treatment arm lasted for eight weeks with a 4-week washout period.
Cognition, blood pressure and urine samples were measured at each visit (five total) while blood and fecal
samples collected at baseline, eight and 20 weeks. Repeated measures ANOVA was used to analyze the
data. Across the treatments, no significant difference was observed for the different domains of
cognition, blood pressure or anti-inflammatory biomarkers. No intervention effect was found for genera or
class of gut microbes. Low anthocyanin nectar derived from the QGP did not have any significant effects
on cognition, blood pressure or gut microbiota in healthy older adults.
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Abstract

Queen Garnet plum (QGP), known for its high levels of anthocyanins, is a hybrid of the
Japanese plum developed in Queensland, Australia. Anthocyanins provide the red, blue and
purple pigments in plants with demonstrated beneficial health effects. This study
hypothesized that low-dose anthocyanin QGP intake will have a significant positive effect on
cognition, blood pressure and gut microbiota in healthy older adults. A randomized crossover
trial was conducted to determine the effect and within subject variance on cognition and 24hr
ambulatory blood pressure in older adults without cognitive impairment following daily
consumption of 200mL low-dose anthocyanin (5mg/100g) QGP nectar (intervention) or
raspberry cordial (control). Secondary outcomes included inflammatory markers (C-reactive
protein), nerve growth factor (BDNF), and gut microbiota (16S rRNA gene sequencing).
Twenty-eight participants (55+ years) were recruited. Each randomized treatment arm lasted
for eight weeks with a 4-week washout period. Cognition, blood pressure and urine samples
were measured at each visit (five total) while blood and fecal samples collected at baseline,
eight and 20 weeks. Repeated measures ANOVA was used to analyze the data. Across the
treatments, no significant difference was observed for the different domains of cognition,
blood pressure or anti-inflammatory biomarkers. No intervention effect was found for genera
or class of gut microbes. Low anthocyanin nectar derived from the QGP did not have any
significant effects on cognition, blood pressure or gut microbiota in healthy older adults.
Keywords: Queen Garnet plum; Anthocyanins; cognition; blood pressure; gut
microbiota; fruit nectar
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1

Introduction

Plums are part of a group of fruits known to contain phytochemicals known as anthocyanins,
a sub-class of flavonoid. There are 19-40 different species of plums that exist of which only
two; the hexaploid European plum (Prunus Domestica) and diploid Japanese plum (Prunus
Salicina and hybrids) are of commercial significance globally [1]. Additionally, different
hybrids of these species have been developed. One such hybrid of the Japanese plum is the
Australian Queen Garnet plum known for its higher levels of anthocyanins (up to
277mg/100g), more than twice the anthocyanin content of regular plums which has been
reported to range from 5-173mg/100g [2, 3].
Anthocyanins are red and purple pigments found in some fruits and vegetables. Besides being
responsible for the color of the fruits, their beneficial health effects continue to be widely
studied for cognition, and blood pressure (BP) [4, 5]. Although these beneficial health effects
have been observed in different populations and using a variety of fruit sources, the complex
metabolism and subsequent bioavailability of these compounds continue to hinder research
efforts. Scientific evidence has emerged showing that anthocyanins are more bioavailable
than originally perceived [6]. This observation stems from an increased interest in the colon
as more than simply an excretion route, but also as an active site for further metabolism of
ingested anthocyanins [7]. Some of the subsequent anthocyanin metabolites are believed to
be more biologically active than intact anthocyanins [8, 9] and are possibly responsible for
some of the observed beneficial effects on cognition (gut-brain axis) and vascular function
(BP). Research on the colonic metabolism of anthocyanins has been faced with limitations,
including the wide inter-individual variability in the metabolic fate of anthocyanins. This
poses one of the largest methodological challenge thus far in determining the health effects
associated with anthocyanin consumption [10].
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Absorption of anthocyanins in the upper gastrointestinal tract is very low, possibly due to
their digestive stability and binding interaction within the food-matrix [11]. As a result, a
considerable amount of intact anthocyanins from fruits can reach the intestinal microbiota
which cleave conjugated moieties, resulting in aglycones. These aglycones undergo ring
fission to produce low molecular weight metabolites including phenolic acids and
hydroxycinnamates which are then reabsorbed into the bloodstream where they are
biologically active [12, 13]. The exact metabolite formation is not clear though in vitro
studies suggest that bacterial metabolism of anthocyanins involves the cleavage of glycosidic
linkages and the breakdown of the anthocyanidin heterocycle [9, 14].
The field of research related to the influence of the gut microbiota on a large array of chronic
diseases including obesity and type 2 diabetes mellitus [15], inflammatory bowel diseases
[16], irritable bowel syndrome [17] and allergies [18], has increased exponentially in recent
years. The gut microbiota profile is also known to possess an important functional role in the
metabolism, immunity and maintenance of a healthy human gut [19] as well as in the
regulation of the gut-brain axis [20]. The GBA involves a two-way communication between
the central and the enteric nervous system that links the emotional and cognitive centers of
the brain, with the peripheral intestinal functions.

It has been shown that even though intact anthocyanins from fruits possesses protective
health effects, their further metabolism and absorption in the colon can lead to considerable
concentrations in the colon lumen and also in the central circulation. In turn, these
metabolites also regulate the growth of specific bacteria in the intestinal microbiota. An
example is an observed increase in the concentration of fecal Bifidobacterium as a result of
anthocyanin microbial metabolites following anthocyanin supplementation [21].
Bifidobacteria are beneficial gram-positive, polymorphic rod-shaped bacteria normally found
5
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in the gastrointestinal tract of humans and animals [22]. In healthy breastfed babies these
bacteria are the dominant microbial group and their levels remain relatively stable, tending to
decrease with advancing age as the bacteria belonging to Bacteroidetes and Firmicutes phyla
are more dominant in adulthood [23]. In recent years, this microbial genus has been studied
extensively due to both its important role within the human intestinal microbiota and the
widespread use of Bifidobacterium strains in probiotic food products.

Evidence from the scientific literature has shown that anthocyanins may exert protective
effects on different domains of cognition, including memory and executive processing, either
through a direct effect on brain function or indirectly by reducing BP and neuroinflammation
[24, 25]. In acute and longer term studies, anthocyanins from fruits including plums have
been shown to have significant clinical benefits on different domains of cognition [26] and
BP [27, 28] as well as proliferative and inhibitory effects on different species of gut
microbiota [29]. These effects have been observed in studies using different study designs,
varying dietary sources and doses of anthocyanins, and a range of health conditions including
individuals with mild to moderate cognitive impairment and hypertension [5].

Anthocyanin-rich fruits are seasonal and variation in their anthocyanin content can occur due
to agricultural factors such as climate, growing conditions, drought and time of harvest [3032]. During the 2018-19 season, anthocyanin content in fresh QGP fruit ranged from 86
mg/100g (early harvest) to 102mg/100g (mid harvest), 149mg/100g (optimal harvest) and
171 mg/100g (very late harvest) (unpublished data; Department of Agriculture, DAF). In
addition, these phytochemicals are highly unstable and susceptible to degradation through
processing [33]. This is problematic when seeking to achieve a standardized food
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intervention necessary for high quality clinical trials, particularly in studies requiring
recruitment over an extended period of time. Unfortunately, many food-based trials do not
consider such variability in dosage within interventions, nor do they monitor change in the
anthocyanin content over time, which challenges the applicability of study findings to dietary
messages. A gap in the literature currently is the investigation of commercial type fruit
products that are marketed as being rich in anthocyanin content. As such, the possibility of
degradation of the anthocyanins in such anthocyanin-rich foods warrants further research into
the potential effect of low anthocyanin foods on different health parameters.

Information in non-cognitively impaired older adults is limited, despite an interest in
maintaining cognitive function in old age. Thus, this study hypothesized that the consumption
of low anthocyanin QGP nectar for eight weeks by healthy older adults (aged 55+ years) will:
1. Have a significant effect on cognition as measured using validated cognitive tests and
24hr ambulatory blood pressure;
2. Have a significant proliferative and inhibitory effect on gut microbiota genera,
Bifidobacteria and Clostridium, respectively; and
3. have a positive effect on the anti-inflammatory biomarkers, serum hsCRP, and BDNF
levels.
From the above hypothesis and expected outcomes, a randomized crossover trial was
designed with the aim to determine the effect, and within subject variance, on primary
measures of cognition and ambulatory blood pressure in healthy older adults following the
daily consumption of processed low anthocyanin QGP nectar or a control beverage with
negligible anthocyanin composition. Changes in the gut microbiota during the clinical trial,
specifically Bifidobacteria and Clostridium genera, and selected anti-inflammatory
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biomarkers were also measured, in order to better understand the mechanism of the clinical
effects.

8

Journal Pre-proof
2

Methods and materials

This study was conducted according to the guidelines of the Declaration of Helsinki, and all
procedures involving human subjects were approved by the University of Wollongong
Human Research Ethics Committee, New South Wales, Australia (HE16/278). This study
was registered with the Australian New Zealand Clinical Trials Registry
(ACTRN12617000220369). The research team were trained in accordance with the ICHGCP guidelines.
2.1

Study design

A randomized, crossover clinical trial was run for a total period of twenty weeks. The cross
over design of the trial allowed for baseline measurements to be collected once, prior to the
start of the trial treatments, rather than at the beginning of each arm [34] (Figure 1).
Participants were randomly allocated to one of two arms (eight weeks on each arm with a
washout period of four weeks) see Figure 2. The intervention arm received QGP nectar and
the control arm received raspberry cordial beverage, that had a similar vitamin C content but
negligible anthocyanin composition. The nutrient composition of the two beverages are
presented in Table 1. Participants were advised to consume 200mL per day (one bottle) of the
provided beverage for the duration of the study arm. The duration of the trial was based on
the findings from previous trial using high anthocyanin cherry nectar [28] which detected
changes in the measured variables as early as six weeks.

2.2

Participants

The participant inclusion criteria were generally healthy adults aged 55 years and older.
Exclusion criteria included: uncontrolled hypertension; type 2 diabetes mellitus (T2DM); any
unstable physical or mental health condition including diagnosed dementia assessed at pre9
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screening interview from participants regular medical check-up sessions; an inability to
provide informed consent; or an inability to communicate in the English language.

Participants were asked about their last regular medical check-up and whether they had been
diagnosed with any of the above conditions prior to enrolment. Participants who were on
antibiotic treatment or had any gastrointestinal diseases were also excluded.

All participants of the current study were recruited from mailing lists within the University of
Wollongong (UOW) and the surrounding Wollongong region. Potential participants had the
opportunity to discuss the study over the telephone prior to the clinic visits and were screened
to determine eligibility. All eligible participants were provided with participant information
sheets (PIS) and a member of the research team was available to answer any questions that
arose. Following provision of the PIS, consenting participants provided written informed
consent prior to baseline measurements being taken.
2.3

Intervention

The QGP nectar was donated by Nutrafruit Pty Ltd. (Yeerongpilly, QLD, Australia), while
the control cordial beverage (Golden Circle Raspberry cordial) was purchased from a major
supermarket chain in Wollongong, NSW, Australia. A random allocation schedule prepared
by an independent statistician was used to randomly assign the participants to either arm.
Researchers were blinded to the allocation though due to the taste and physical differences,
participants were able to tell the difference between the beverages.

An independent research assistant packed the appropriate beverages into a sealable cooler bag
to be delivered to participants’ home on a fortnightly basis. No change to the regular diet was
10
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advised. Participant compliance was recorded from unconsumed returned bottles every
fortnight.

Data collection was performed over five visits: baseline, four weeks, eight weeks which was
the end of arm one as well as 16 weeks and 20 weeks which was the end of arm two after
crossover (Figures 1 and 2). Participants were required to attend their clinic visits in a fasted
state for the baseline, and eight-week data collection time points of each arm which involved
collection of fasting blood samples for the anti-inflammatory biomarkers (hsCRP and BDNF)
measurements. On clinic days, participants were provided with a standardized breakfast (two
wheat biscuits, full cream milk, and English breakfast muffin) after the blood sample
collection and before the administration of the battery of cognitive tasks. The standardized
breakfast provided 1314kJ energy and 64.8g carbohydrate (source: food label). For the fourweek visits of each arm, participants had their usual breakfast at home prior to attending the
testing facility.

2.4

Anthocyanin characterization of the intervention beverage

Determination of concentrations of anthocyanins in the intervention nectar was conducted at
seven time points during four months of the trial using the validated AOAC pH-differential
spectrophotometric method (Spec. AOAC) [35], a spectrophotometric procedure specifically
designed to determine the total anthocyanin content in fruit juices and fruit-based products,
by a laboratory at the University of Wollongong [36]. This method applies the principle that
monomeric anthocyanins reversibly change color with change in pH; colored flavyllium form
exists at pH 1.0, while colorless hemi-ketal form predominates at pH 4.5. The difference in
absorbance at 520 nm is deemed proportional to the pigment concentration. The anthocyanin
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concentration of the nectar was also conducted eight months after the completion of the trial
by laboratories of the Queensland DAF using a HPLC-based protocol, as well as the AOAC
pH-differential method (Spec.AOAC) described above. The HPLC-chromatograms
established that the cyanidin-3-glucoside was the predominant anthocyanin in the QGP
nectar, with cyanidin-3-rutinoside the next most abundant, contributing over 95% of the total
anthocyanin content. Water soluble anthocyanins were extracted using an acidified waterorganic solvent and prepared for separation and determination. Briefly, ≈ 5.0 g of the thawed
puree was weighed into a 50 mL centrifuge tube followed by 15 mL of extracting solution
(4% formic acid in deionized water: 100% methanol in the ratio 20:80 v/v). This was
sonicated for 10 min with occasional shaking at ambient temperature, then centrifuged at
3220g for 5 min. The supernatant was transferred to a 50 mL volumetric flask while the
residue was re-submitted for extraction another two times. The three supernatants were
combined and made to volume in a 50 mL volumetric flask with extracting solution as above.
An aliquot was diluted 50:50 with 2% formic acid in deionized water and filtered through a
13 mm 0.22μm PTFE syringe filter into a vial prior to analysis. All extractions were
performed in triplicate. HPLC methods were a modified version of those described by
Kammerer et al. (2004) [37]. Samples were analyzed using a Shimadzu HPLC system linked
to LabSolutions software (Shimadzu Co., Kyoto, Japan). Separation of the anthocyanins were
achieved on a reversed-phase Gemini NX-C18 (Phenomenex,Sydney, Australia) 5µm-250 x
4.6 mm with matching guard column,

maintained at 30 0C. A calibration equation was

calculated from the curve of peak area versus standard cyanidin-3-glucoside concentration
and applied to the peak areas of identified anthocyanins; concentrations were calculated after
applying the appropriate dilution factor. The concentrations of the predominant anthocyanin,
cyanidin-3-glucoside together with all of the other identified anthocyanins are expressed as
mg of cyanidin-3-glucoside equivalents/100 g fresh weight.

12
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2.5

Outcome variables

The primary outcome measure was change from baseline in cognitive parameters measured
by five different cognitive tasks while the secondary outcome measures included change from
baseline in BP parameters (systolic BP, siastolic BP, mean arterial pressure, heart rate and
pulse pressure), inflammatory biomarkers (hsCRP) and brain derived neurotrophic factor
(BDNF) in the blood samples, as well as the gut microbiota.

A battery of five cognitive tests, including the Rey Auditory Verbal Learning Test (RAVLT)
[38], verbal fluency task [39], digit-span backwards task [40], Stroop task [41], and counting
span [42], was administered to assess participants’ cognition and memory. The RAVLT
measured verbal learning and memory, which involved participants learning a list of words
over presentation-test and delayed-test trials. Verbal fluency measured executive function,
requiring participants to produce as many words as possible that belonged to a category
(animals, vegetables or fruits) or began with a specific letter (‘A’, ‘C’, ‘B’, and ‘F’). The
digit-span backwards task assessed short-term memory storage and executive function by
requiring participants to repeat a series of numbers in the reverse order they were given. The
Stroop task assessed executive function whereby participants were provided with a sheet on
which the words green, yellow, red, and blue were printed (20 in total) in either congruent or
incongruent ink colors (e.g., the word “blue” printed in red). The aim was to name the actual
colors and not the printed words, as quickly as possible. Two versions of the Stroop task
(congruent and incongruent ink colors) were applied and analysis was based on the time
difference between the two tasks. The counting span task assessed working memory. In this
task participants were presented with displays of light and dark blue shapes (squares and
circles) and are asked to count the number of dark blue circles on each slide. After a series of
displays (between two and six), participants were asked to recall the count for each display in
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the series, in the order in which they occurred. Participants were familiarized with the
cognitive tests prior to data collection on the first day of each clinic visit, for a period of
about 10 minutes.
Demographic and lifestyle questionnaires were completed by participants. The International
Physical Activity Questionnaire validated by Hagströmer et al. (2006) [43] was used to
determine habitual level of physical activity. For dietary data, participants were required to
complete a 24-h dietary recall questionnaire, as well as a 3-day estimated food record all food
and beverages consumed over two non-consecutive week-days and one weekend day. For
baseline and the follow-up appointments, anthropometric measures including weight, height,
waist and hip circumference, as well as physical measure (30-second sit-to-stand, and gripstrength) were collected detailed below.
Two BP measurements (24h and office) were taken. Twenty-four-hour ambulatory BP was
taken using Welch Allyn ABPM (Welch Allyn, NSW, Australia; Model 7100) and spot BP
measured according to a standard protocols [44] using Welch Allyn Spot Vital Signs LXi
DXEmed Com.
The blood samples collected were spun in a centrifuge for 15 minutes at 3000rpm after 30
minutes of collection. The serum was collected in 2mL sterile tubes and stored at -80oC for
batch analysis by an independent laboratory (Cardinal Bioresearch Pty Ltd. Queensland,
Australia) for BDNF (Brain-derived neurotrophic factor) and hsCRP levels. Serum BDNF
was analyzed using an R&D Systems Duo ELISA kit (Intra assay CV 3% and Inter assay CV
4%, Lowest Detectable Dose 5 ng/mL). Serum hsCRP was analyzed using a BioBase
immunoturbidimetric assay. The assay was run on a BioBase BK400 chemistry analyzer
(BIOBASE, Shandong, China) (Intra assay CV 3.5% and Inter assay CV 5%, Lowest
Detectable Dose 0.2 ng/mL). Furthermore, urine samples were screened for anthocyanins and
their common conjugated and methylated metabolites by UHPLC-PDA-ESI-MS/MS [45].
14
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Fecal samples were collected using commercial uBiome™ (San Francisco, CA, USA) gut
kits. Participants were advised to collect their fecal samples following a bowel movement.
Samples were collected from toilet paper using the provided instruments. The microbiome
analysis by uBiome was done using 16S-sequencing on the Illumina Next Generation
Sequencing platform that delivers sequence data [46]. 16S is a ribosomal gene present in
bacterial DNA that enables the classification of bacteria at the genus level and in addition
filters out genetic material from humans and other organisms. Of the three bacterial rRNA
genes (16S, 5S and 23S), the 16S rRNA gene provides the most tractable combination of
conserved sites for Polymerase chain reaction (PCR) primers and is, therefore, preferable to
the other rRNA genes for phylogenetic identification [46]. This method of sequencing is
commonly employed in gut microbiota studies creating less heterogeneity in studies for
comparison.

Two trained assessors measured grip strength using a digital Jama handgrip dynamometer
(Lafayette Instruments, City, IN, USA). Participants were seated with their elbow bent at 90o.
With a neutral wrist position, the dynamometer handle was held at position II, with the
dynamometer supported underneath [47] and grip strength recorded for both left and right
hands, and hand dominance noted. Height (in meters) and weight (in kilograms) were
measured using a stadiometer (Seca, Hamburg, Germany) and an electronic scale (Omron
HN286 Digital Personal Body Weight Scale; Omron, Silverwater, NSW, Australia),
respectively, to two decimal places, and body mass index (weight/[height 2]) was calculated.

2.6

Statistical Analyses

The sample size for this study was calculated using GPower [48]. Previous work from our
group [28] has found a moderate magnitude of effect of anthocyanin supplementation on

15

Journal Pre-proof
memory, however, the aim of the current study was to detect a smaller effect size of 0.3. To
obtain a power of 0.90, n = 30 participants were needed, including a 10% expected dropout.
All statistical analysis was carried out using Statistical Package for the Social Sciences
(SPSS) software (version 22.0, Chicago, IL, USA). Normal distribution of the continuous
variables was assessed using the Shapiro-Wilk test, histogram, Q-Q plot and skewness and
kurtosis. Continuous data are presented as means ± SD for normally distributed data and
median (IQR) for non-normally distributed data. Differences between baseline and four and
eight weeks of each study arm were analyzed using paired sample t-tests for continuous
variables and chi-square test for categorical variables.
Repeated measures ANCOVA was used to determine the effect of time, treatment and
time*treatment interactions for cognition and blood pressure measurements at four and eight
weeks of each arm, and the biomarkers of inflammation at baseline and eight weeks of each
arm. Alpha was set at 0.05 for statistical significance. The statistical analysis controlled for
baseline measurements and randomization order as potential confounders. To avoid a
significant reduction in the power of the study, no other covariates were included in the
analysis due to the small sample size. However, there were no significant differences in the
demographics according to the order of allocation.
Dietary anthocyanin intake was determined from the 24-h recall dietary assessments using an
Australian anthocyanin database aligned to the AUSNUT 2011-13 database [27] available
within the dietary analysis FoodWorks professional software (Version 8, 2009, Xyris Pty Ltd,
Spring Hill, QLD, Australia). All participants were included in the final data analysis (i.e.
intention-to-treat).
The linear discriminant analysis effect size (LEfSe) tool [49] was used to analyze gut
microbiota data.

16
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3

Results

Thirty-one participants (14 males and 17 females) were recruited between January and March
2018. Twenty-eight (90.3%) participants completed the trial. Three participants withdrew;
two due to illness and one due to involvement in an accident (Figures 1 and 2). All
participants who completed the study attended all five visits and no adverse reactions were
reported throughout the study duration. The mean washout period for participants was six
weeks, a deviation from the original four-week washout period due to scheduling clashes and
illness.
3.1 Baseline
Baseline characteristics of participants are summarized in Table 2, with no significant
differences seen in any variables according to the order of randomization. The mean age of
the participants was 70 ± 10 years old with a mean BMI of 26 ± 4 and waist-hip ratio of 0.88 ±
0.09. Forty-five percent of the participants had a post-graduate qualification and 45% reported

high physical activity levels. Baseline ambulatory blood pressure was within the normal
range with a mean systolic BP of 129 ± 12 mmHg and mean diastolic BP of 80 ± 9 mmHg.
Seven participants (23%) were on BP medications that remained stable during the duration of
the trial.

3.2 Cognition and physical measurements
There was no observed significant difference from baseline or between arms for the battery of
cognitive tests performed with the participants, nor for any of the physical tests (Table 3).

3.3 Ambulatory blood pressure and anti-inflammatory biomarkers (BDNF and hsCRP)
Similar to the cognitive outcomes, there were no observed significant effects observed in the
24-h ambulatory BP (Table 4).
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In addition, measured anti-inflammatory biomarkers (BDNF and hsCRP) (Table 5) did not
show any significant difference from the baseline measures.

3.4 Gut microbiota
There were no significant differences observed for the Bifidobacterium and Clostridium
genera. These bacteria genera have previously been shown to be affected by anthocyanin
supplementation [29]. Further analysis of gut microbiota data showed that there were no
biomarkers associated with QGP nectar consumption over the eight-week intervention arm.

3.5 Urine
Cyanidin-3-glucoside and cyanidin-3-rutinoside, the main QGP anthocyanins, as well as
cyanidin monoglucuronide, peonidin monoglucuronide and peonidin-3-rutinoside, the most
common methylated/conjugated metabolites of cyanidin-based anthocyanins, were tentatively
identified in some urine samples after QGP nectar consumption (Table 6). However, further
evaluation was not undertaken since the concentrations of these anthocyanins and metabolites
were below the limits of quantification; no other conjugated or methylated anthocyanin forms
could be detected. Furthermore, no intact anthocyanins or common anthocyanin metabolites
could be identified in the control samples (consumption of cordial beverage).

3.6 Dietary data
Analysis of participants’ background diet is presented in Table 7. The mean intake of dietary
anthocyanins was 143 ± 218 mg/day (median 34.2mg/d (IQR =280)).

During the trial, the anthocyanin concentration of the QGP nectar using the AOAC- pHdifferential method ranged from 3.72 to 5.27 mg C3G eq./100g fresh weight which would
have provided between 6.74 and 10.54 mg anthocyanins per day. Eight months after
completion of the study, mean (SD) anthocyanin concentration of the frozen, stored plum
18
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nectar was 3.7±0.3 (mg C3G eq.)/100g fresh weight and was 6.3±0.5 (mg C3G eq.)/100g
fresh weight.
4

Discussion

This study hypothesis that the consumption of QGP nectar for eight weeks would have
significant beneficial effects on domains of cognitive function, as well as result in reductions
in BP and inflammatory biomarkers (hsCRP, BDNF) and changes in gut microbiota,
compared to a control beverage, was not proven in a group of healthy older adults. Results
from this study demonstrate that in healthy older adults without cognitive decline,
supplementation with commercially available QGP nectar that had undergone heat treatment
as part of the industrial processing of fresh plum fruit into nectar, appears to provide no
beneficial effects. The QGP has been shown to contain a wide variety of anthocyanins and
phenolics [45] and in its fresh state is a rich source thereof. However, preservation of these
anthocyanins remains a challenge when the fruit is processed into nectar and stored over
time. We have demonstrated that the anthocyanin composition of the intervention nectar was
lower than expected in the present study, providing around 9mg per day.
Processing and storage times likely affected the anthocyanin stability in the intervention
nectar and, subsequently, may explain the absence of any significant changes in measured
variables. Due to the short growing season of plums in Australia, and the extended period of
time typically required in clinical trials to recruit sufficient numbers of participants, we
endeavored to standardize the provided nectar by using two combined batches that had been
processed. This necessitated the nectar to be kept in storage under controlled conditions for
over ten months (frozen) while the total study duration was eight months. Evidence shows
that the processing of fruits to juice, especially using high temperatures, significantly
degrades anthocyanins [33]. In addition, the thawing and freezing process involved in
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bottling of the nectar could have also resulted in further degradation of the plum nectar
anthocyanins [50]. This degradation effect, together with the low stability of anthocyanins in
general, could have significant effects on health outcomes, thereby limiting the generalization
of our research findings [51]. However, eight months after completion of this trial, the HPLC
analysis of the frozen stored plum nectar showed no further degradation.
Anthocyanins from fruits have been shown to exert a protective effect on cognition even in
the presence of other polyphenols. A randomized, double-blind, placebo-controlled study
compared the safety and efficacy of encapsulated low dose enhanced wild blueberry extract
(WBE111) in healthy older adults (65-80 years). Two doses of wild blueberry powder
(500mg and 1000mg) were compared to a formulated wild blueberry extract, Thinkblue™
wild Blueberry Extract (111mg; WBE111). The anthocyanin doses across the three
interventions were 1.35, 2.7 and 7mg/dose/day, respectively. The authors observed
significantly better episodic memory performance following WBE111 at three months and
lower systolic BP following intervention with WBE111 in comparison to placebo, even
though one of the doses of wild blueberry powder (1000mg) contained more total
polyphenols than the WBE supplementation (70mg/dose/day vs 50mg/dose/day) [52]. Other
studies using grape and/or blueberry juice (87mg of anthocyanins per 100g and
1920mg/100g, respectively) observed significant effects on episodic and working memory
[53, 54], as well as systolic BP in older healthy adults for six months [55] and individuals
with mild-moderate cognitive impairment [28]. However, the study by Bensalem et al. (2019)
[55] only found the benefits of anthocyanin supplementation following stratification of the
participant data according to baseline cognitive characteristics, with memory benefits only
seen in those with poorer function initially. Other studies that have provided higher doses of
anthocyanins from fruits than in the current study have similarly not found health benefits in
healthy older adults who have no prior cognitive deficit [56, 57].
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Our study findings are consistent with similar studies on healthy older adults using a
crossover study design [58, 59] as well as a parallel study design using elderberries [60] . In
one of the studies [59], 80 mg of anthocyanin extract from bilberry (blueberry) (Vaccinium
myrtillus) and black currant (Ribes nigrum) were consumed in capsule form. While it is
possible to encapsulate anthocyanins [61], which may make anthocyanin consumption easier
to control by improved compound stability, the bioactive benefits of extracting and isolating
the specific flavonoids via encapsulation has been questioned [62], as this process may
adversely impact bioavailability.

Comparison across studies that report significant positive effects and those that have not
found anthocyanin-related health benefits suggest the following four important differences: a
longer duration of intervention (three to six months); food source of anthocyanin (usually
blueberry); study design (parallel vs cross over); and cognitive function (individuals with
mild cognitive impairment vs no cognitive decline). Positive studies have tended to use fruits
such as blueberries and grapes that contain a wider range of anthocyanin sub-classes, rather
than a fruit vehicle that contains mostly contains cyanidins such as the plum used in our study
[63]. To further demonstrate an effect of a combination of anthocyanin sub-classes, a study
that compared enocianin, a grape extract containing a variety of anthocyanins, with a pure
malvidin-3-glucoside extract reported a more significant proliferative effect on gut bacteria
with enocianin [64]. The synergistic effect of both nutrients and bioactive non-nutrient
components within a food matrix has been highlighted by Jacobs and Tapsell (2007) [65, 66].
This is an important consideration in planning and executing nutrition research that is
relevant for translation into dietary guidance.
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A recent meta-analysis on the effect of anthocyanin-rich foods on cardiometabolic
biomarkers found that berries and red grapes/wine significantly reduced BP. These effects
were detected in overweight/obese individuals but not in normal weight individuals [55].
Available evidence suggests that in healthy older individuals, lower levels of anthocyanin
supplementation do not seem to have significant effects over the short term (≤ two months)
on either blood pressure or cognition. A study using anthocyanin-rich blood orange juice
(50mg of anthocyanins/500mL) did not observe any effect on BP in healthy people (2584yrs) over four weeks [58]. On the other hand, studies of dementia patients (69mg of
anthocyanins /100ml; 139mg/d) [28] and post myocardial infarction patients (64mg/d) [67]
reported significantly reduced BP over 12 weeks. Another important consideration for the
study design is the differential effects seen in acute vs longer-term interventions. In acute
settings, positive effects have been observed on cognition and BP both in children and adults
[26, 68, 69] and also in longer-term studies on individuals with mild to moderate cognitive
impairment [26, 28]. However, these acute effects in healthy older adults are not generally
seen chronically [58] except in studies where blueberries have been supplemented over a
longer term (3-6 months). There is no clear explanation for this observation except for the
difference in duration, anthocyanin vehicle, study design and possibly metabolism. Evidence
has suggested that a chronic intake of flavonoids does not result in increased levels of
metabolites in the tissues compared to single doses; which show that brain levels are likely
reflective of acute intake and may not accumulate over the longer term [70]. The lower than
expected quantity of anthocyanins present in the plum nectar used in the current study is
confirmed by an inability to determine the concentrations of anthocyanin metabolites in the
urinary excretion of the participants, which were below the limits of quantification.
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In line with the absence of any significant effects on cognition, no changes in either BDNF or
the inflammatory biomarker, hsCRP, were observed following anthocyanin supplementation
from QGP nectar. BDNF is an important growth factor for synaptic plasticity and learning
and memory [71, 72] while hsCRP is a broad marker for inflammatory state. Our hypothesis
was that anthocyanins would exert protective effects on memory and cognition through a
subsequent increase in BDNF levels, amongst other pathways. In animal models,
anthocyanins have been shown to increase BDNF levels [73] but there is little available
evidence from human clinical trials. The only available evidence is from an acute trial [74]
which showed stable BDNF plasma levels following blueberry anthocyanins supplementation
in adults compared to a reduction associated with consuming a control beverage. It is
important to note that the baseline CRP and BDNF concentrations were within normal ranges
(CRP < 3mg/L and BDNF between 8–46 ng/mL [75]) which may explain the lack of change
in these biomarkers. It has been suggested that anthocyanin-rich interventions tend to exert
beneficial effects on the cardiovascular system in participants with clinically diagnosed
disease compared to healthy subjects, where no significant effects are observed [60]. A
review of anthocyanin effects on CRP levels from clinical trials also observed that purified
anthocyanins or anthocyanin-rich extract supplementation did not have any significant impact
on CRP levels [76].

In terms of effects of anthocyanins on gut microbiota, anthocyanins may have a significant
proliferative effect on Bifidobacterium spp., known for their wide use in probiotics and for
the treatment of irritable bowel syndrome as well as an inhibitory effect on the pathogenic
strain Clostridium [29]. Our study did not find an intervention effect on these genera of gut
bacteria nor on any other microbiota genera. Studies on the effect of anthocyanins on gut
microbiota have observed proliferative and inhibitory effects on different bacteria species but
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the effect on total bacteria count has not been consistent [29], and they may have proliferative
and inhibitory effects of a similar magnitude in different species [77].

The absence of significant effects on the primary outcome measures could also be associated
with the background dietary intake. Anthocyanin intakes in the Australian population have
been estimated at between 1.4 -24.2mg/d [78]. However, the median intake of dietary
anthocyanins in our study population was 34.2 (IQR = 280.3) which is considerably higher
than intakes reported in other Australian studies [79, 80]. Significant associations have been
demonstrated between habitual anthocyanin intakes and reduced disease risks in
epidemiological studies [81-83], therefore a high background dietary anthocyanin intake may
have hindered any possible additional benefits from a relatively low dose of anthocyanin
supplementation. Additionally, the standardized breakfast provided to participants prior to
administration of their cognitive tests at baseline and in both study arms had minimal
anthocyanin content but provided 1314kJ and 64.8g of carbohydrate. Research on the effect
of breakfast and breakfast composition on cognitive outcomes is inconclusive, however,
available evidence shows that there are no observed effects on cognition following a
carbohydrate dense breakfast [84].

One of the main strengths of this study was the crossover design. Participants acted as their
own control which accounted for inter-individual variances and thereby increasing the
statistical power. In crossover trials, three types of baseline measurements have been
described: those taken before the start of the first arm, those taken at the end of the first arm
and before the start of the second arm, and those taken at the end of the second arm. The first
type has been described as a true baseline as there is always the possibility that carry-over
effects may be present in the second and third type [34]. Additionally, as comparisons are
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within each trial participant, it has been suggested that different baseline measurements are
not compulsory. Hence for this study baseline measurements were recorded only once at the
start of the trial. It is also of note that there were few dropouts in our study and the nectar
consumption compliance was satisfactory (100%).
A limitation of our study was the inability to blind participants due to differences in the taste,
texture and appearance of the intervention and control beverages. Other limitations include
lack of quantification of the total phenolic content of the study beverage which may shed
some light on the lack of effect on gut-brain axis. Additionally, the duration of the
intervention may have been too short to elicit effects. A major consideration in the design of
anthocyanin food-based research is related to preservation of the anthocyanin composition in
test foods. Losses in the anthocyanin composition of the nectar due to the bottling process
(repeated freeze-thawing) and other storage considerations presented a real challenge.
Another nutrient-related limitation might relate to the difference in energy content between
the intervention and control beverages (213kJ vs 115kJ) despite matching for vitamin C
content. The nutrient content for the QGP nectar was analyzed by collaborators of the current
study and the nutrient content for the control juice was available on the label, unless
otherwise stated. The difference in methodology could be seen as a limitation in this study.
Closer matching for total nutrient composition, except the relevant bioactives of interest is
recommended for future studies. Another recommendation for future studies is quantification
of anthocyanin phenolic acid metabolites which was not conducted in the current study.

In conclusion, our research hypothesis was rejected as low-dose anthocyanin supplementation
provided in a food matrix of QGP nectar did not have any significant effect on cognition, BP,
or nerve growth factor/ inflammatory markers (BDNF and CRP) over eight weeks but may
have an effect on the gut microbiota population in healthy older individuals. Future research
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may consider stability of anthocyanins while focusing on supplementation with other
available fruits with different anthocyanin profiles in longer-term (3-6 months) crossover
studies in order to confirm the absence of a chronic effect from fruit anthocyanins at this level
of concentration.
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Table 1: Anthocyanin and macronutrient composition of the two study beverages

QGPJ (per 100mL) b

Raspberry cordial (per 100mL) d

Anthocyanins (mg C3Ga eq.)

3.7-5.3c

0.4b

Energy (kJ)

213

115

Protein (g)

1.1

0

Total fat (g)

0.1

0

Total carbohydrate (g)

8.7

6.5

Sugars (g)

8.7

6.5

Dietary fibre (g)

<0.1

<0.1b

Vitamin C (µg)

<0.05

<0.05b

a

Cyanidin-3-glucoside equivalents; b Data from Santhakumar et. al. (2015)[85]; c Analyzed by University of
Wollongong and Department of Agriculture and Fisheries; d Nutrient content from label.
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Table 2: Baseline characteristics of the study population

n (%)

ICa sequence
(n=16)
n (%)

Gender
Male
Female

14 (45)
17 (55)

6 (37)
10 (63)

8 (53)
7 (47)

ns

Age, years (means ± SD)

70 ± 10

69 ± 10

70 ± 10

ns

BMI, kg/m2 (means ± SD)

26 ± 4

25 ± 4

27 ± 4

ns

0.88 ± 0.09

0.86 ± 0.09

0.89 ± 0.10

ns

Level of education
Secondary
TAFE/Diploma
University degree
Post-grad

4 (13)
9 (29)
4 (13)
14 (45)

1 (6)
4 (25)
4 (25)
7 (44)

3 (20)
5 (33)
0 (0)
7 (47)

Marital status
Married
Divorced
Widowed

22 (71)
5 (16)
4 (13)

14 (88)
2 (12)
0 (0)

8 (53)
3 (20)
4 (27)

Physical activity
High
Medium
Low

14 (45)
12 (39)
5 (16)

7 (44)
4 (25)
5 (31)

7 (47)
8 (53)
0 (0)

BP medication
Yes
No

7 (23)
24 (77)

1 (6)
15 (94)

6 (40)
9 (60)

24 ABPM (mean ± SD)
SBP
DBP
MAP
HR
PP

129 ± 12
80 ± 8
102 ± 9
72 ± 9
49 ± 9

126 ± 11
79 ± 7
100 ± 8
72 ± 10
47 ± 10

132 ±12
81 ± 9
104 ± 9
72 ± 8
51 ± 8

Spot Blood Pressure
SBP
DBP
PR

131 ± 19
75 ± 9
74 ± 14

127 ±20
74 ± 9
79 ±16

136 ± 18
77 ± 9
69 ± 9

Hand grip strength
(mean ± SD)
Right
Left

30.1 ± 10.3
26.8 ± 10.6

29.3 ± 9.6
25.1 ± 9.8

30.9 ± 11.2
28.6 ± 11.5

Baseline characteristics

Waist-Hip ratio
(mean±SD)

Full cohort (n=31)

CIb sequence
(n=15)
n (%)

pvalue

ns

ns

ns

ns
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Baseline characteristics

Sit-to-stand (mean ± SD)

CIb sequence
(n=15)
n (%)

pvalue

n (%)

ICa sequence
(n=16)
n (%)

19 ± 7

19 ± 8

18 ± 5

ns

Full cohort (n=31)

Cognitive assessment
(mean ± SD)

RAVLT total (I-V)
RAVLT delayed recall
RAVLT 20m delayed
recall

ns
43 ± 12
8±4
8±4

44 ± 11
8±3
9±4

41 ± 14
8±4
8±5

Digit Span (mean ± SD)

7±3

7±3

7±3

ns

Letter fluency (mean±SD)

14 ± 6

14 ± 6

14 ± 7

ns

Category fluency
(mean±SD)

17 ± 6

18 ± 6

15 ± 6

ns

Counting span
(mean±SD)

9±4

8±4

10 ± 3

ns

Stroop (secs) (mean±SD)

12 ± 6

14 ± 7

10 ± 4

ns

Inflammatory
biomarkers/ nerve
growth factor
hsCRP (mg/L)
BDNF (ng/mL)

ns
1.56 ± 1.67
37.7 ± 10.4

1.44 ± 1.22
35.4 ± 12.5

1.70 ± 2.11
40.2 ± 6.99

Data are means ± SD or n (%) (n=31); P values were obtained from χ2 test for categorical variables; Ns- Not significant
a
IC- intervention- then control order (n=16); bCI- control then intervention order (n=15); RAVLT-Rey auditory verbal learning test; 24ABPM – 24-h Ambulatory Blood Pressure Monitor; BMI – Body Mass Index; SBP-systolic blood pressure; DBP-diastolic blood pressure;
MAP-mean arterial pressure; HR-heart rate; PP-pulse pressure; PR-pulse rate; hsCRP- high sensitivity c- reactive protein; BDNF- Brainderived neurotrophic factor
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Table 3: Crossover analysis of cognitive and physical function variables
Means ± SD
Baseline

4-weeks

p-values ANOVA analyses
8-weeks

RAVLT total (I-V)

Treatment
effect

Time
effect

Treatment
* time
effect

0.69

0.74

0.44

0.49

1.0

0.43

0.41

0.77

0.72

0.23

0.14

0.49

0.73

0.63

0.94

0.58

0.47

0.20

0.35

0.90

0.96

0.08

0.72

0.08

0.90

0.59

0.88

0.53

0.81

0.30

43 ± 12
Plum nectar
Cordial

48 ± 11
48 ± 13

49 ± 11
49 ± 12

RAVLT delayed
recall
8±4
Plum nectar
Cordial

9±4
9±4

9±4
9±4

RAVLT 20m
delayed recall
Plum nectar
Cordial

8±4
9±3
9±5

9±4
9±4

Digit Span
Plum nectar
Cordial

7±3
8±2
8±3

8±2
8±2

Letter fluency
Plum nectar
Cordial

14 ± 6

15 ± 6
16 ± 7

16 ± 6
15 ± 6

Category fluency
Plum nectar
Cordial

17 ± 6

15 ± 5
19 ± 7

16 ± 6
18 ± 7

Counting span
Plum nectar
Cordial

9±4

9±3
10 ± 3

10 ± 3
10 ± 3

Stroop (secs)
Plum nectar
Cordial
Hand grip strength
Right

12 ± 6

11 ± 5
10 ± 6

10 ± 5
9±5

30.1 ± 10.3
32.4 ± 11.0
31.3 ± 10.6

Plum nectar
Cordial
Left

31.9 ± 11.1
31.7 ± 11.0

26.8 ± 10.6
Plum nectar
Cordial

29.3 ± 10.7
28.6 ± 11.3

29.2 ± 11.3
27.6 ± 10.1
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Means ± SD
Baseline

4-weeks

p-values ANOVA analyses
8-weeks

Sit-to-stand

Treatment
effect

Time
effect

Treatment
* time
effect

0.34

0.12

0.12

19 ± 7
Plum nectar
Cordial

21 ± 8
21 ± 9

21 ± 7
22 ± 9

Data are means ± SD (full cohort n=31); P values were obtained from repeated measures ANOVA test for categorical.

Table 4: Crossover analysis of 24-h Ambulatory blood pressure data

Means ± SD
Baseline

4-weeks

p-values ANOVA analyses
8-weeks

SBP

Treatment
effect

Time
effect

Treatment
* time
effect

0.73

0.97

0.44

0.41

0.92

0.86

0.75

0.93

0.71

0.37

0.06

0.62

0.77

0.97

0.39

129 ± 12
Plum nectar
Cordial

126 ± 10
124 ± 11

127 ± 10
123 ± 8

DBP
80 ± 8
Plum nectar
Cordial

79 ± 8
76 ± 7

78 ± 8
76 ± 7

MAP
102 ± 9
Plum nectar
Cordial

100 ± 8
98 ± 8

101 ± 8
97 ± 6

Heart rate
72 ± 9
Plum nectar
Cordial

71 ± 10
69 ± 9

71 ± 8
71 ± 9

Pulse pressure
49 ± 9
Plum nectar
Cordial

48 ± 8
48 ± 9

50 ± 10
46± 8

Data are means ± SD (full cohort n=31); P values were obtained from repeated measures ANOVA test for categorical.

36

Journal Pre-proof
Table 5: Crossover analysis of nerve growth factor / inflammatory biomarkers (BDNF
and CRP)

Measurements
Baseline

p-values ANOVA analyses

8-weeks

Treatment effect

Treatment
* baseline

0.70

0.67

0.17

0.16

BDNF (ng/mL)
37.7 ± 10.4
Plum nectar
Cordial

33.6 ± 12.1
33.7 ± 11.5

CRP (mg/L)
1.56 ± 1.7
Plum nectar
Cordial

2.66 ± 4.0
2.19 ± 2.2

Data are means ± SD (full cohort n=31); P values were obtained from repeated measures ANOVA test for categorical.

Table 6: UHPLC-PDA-ESI-MS/MS characterization of QGP anthocyanins and metabolites
detected in human urine after the consumption of QGP nectar.

Compounds
Proposed identity
Cyanidin-3-glucoside
Cyanidin monoglucuronide
Cyanidin-3-rutinoside
Peonidin monoglucuronide
Peonidin-3-rutinoside

Precursor ions (m/z)

Empirical molecular

[M+H]+

formula

449.15

C21H21O11+

287.05

463.10

C21H19O12

+

287.05

C27H31O15

+

449.10, 287.05

C22H21O12

+

301.10

C28H33O15

+

463.15, 301.10

595.15
477.10
609.15

Fragments
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Table 7: Dietary data analysis of participants

Nutrient/day

Full group (n=31)

a

Anthocyanin (mg)

142.69 ± 217.58
(34.15(280.33))

152.42 ± 264.77
(35.05(149.75))

132.97 ± 167.40
(27.35(287.83))

ns++

Energy (kJ)

9302.9 ± 3035.89
(9065 (3245))

9716.74 ± 3536.54
(9209 (4310.5))

8889.06 ± 2503.24
(9040.95 (3347.4)

ns

Carbohydrate (g)

209.66 ± 62.71
(193.6 (81.93)

201.37 ± 55.45
(185.05 (62.65)

217.96 ± 70.31
(213.65 (86.93))

ns

Protein (g)

94.59 ± 24.87
(87.4 (50.5))

93.49 ± 33.69
(80.50 (59.45))

95.69 ± 24.35
(92.40 (49.5))

ns

Total Fat (g)

94.92 ± 42.92
(86.9 (59.72))

107.77 ± 51.44
(94.45 (59.8))

82.06 ± 28.70
(78.5 (30.93))

ns

Saturated Fat (g)

30.76 ± 10.55
(29.6 (12.85))

30.96 ± 11.38
(31.4 (17.45))

30.56 ± 10.09
(28.05 (8.95))

ns

Dietary fibre (g)

32.23 ± 12.73
(30.25 (20.55))

34.39 ± 15.16
(33.5 (22.2))

30.08 ±9.86
(28.5 (18.1))

ns

Sodium (mg)

2304.36 ± 815.33
(2118.39 (972.22))

2266.09 ± 752.97
(2095.15 (1013.92))

2342.63 ± 900.30
(2150.07 (968.08))

ns

Potassium (mg)

3746.13 ± 1192.90
(3642.36 (1146.08))

3744.75 ± 1372.60
(3478.31 (1171.54))

3747.51 ± 1035.12
(3807.56 (1396.32))

ns

Magnesium (mg)

404.21 ± 189.00
(379.04 (231.79))

418.47 ± 243.15
(354.89 (344.22))

389.94 ± 120.96
(427.91 (237.05))

ns

Calcium (mg)

1056.97 ± 431.95
(912.71 (471.96))

978.89 ± 432.43
(858.26 (395.33))

1135.05 ± 432.89
(977.80 (456.62))

ns

Iron (mg)

13.83 ± 7.00
(11.82 (7.29))

14.14 ± 6.57
(11.82 (10.00))

13.53 ± 7.64
(11.55 (6.72))

ns

Omega 3 (g)

2.45 ± 1.82
(1.83 (1.75))

3.21 ± 2.25
(2.68 (2.72))

1.69 ± 0.77
(1.41 (1.06))

0.024

IC sequence (n=16)

b

CI sequence (n=15)

p value+

Values are means ± SD and (medians (IQR)); IC- intervention- then control order, n=16; CI- control then intervention order, n = 15; ns- not
significant; +t-test; ++Wilcoxon signed-rank test
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